Abbott Remains on the Dow Jones Sustainability Indexes for the 6th Consecutive Year Abbott was once again included on both the Dow Jones Sustainability World Index and THE UNITED STATES Index, following the reassessment of 2010 scores announced by Dow Jones Indexes and SAM. This is the sixth consecutive yr that Abbott offers been called to both Dow Jones Sustainability Indexes . Abbott was named the market leader in a number of categories, including a score of 100 % in environmental environment and management strategy, key regions of focus in the business’s comprehensive effort to guard the environment.Al-Khalidi, Ph.D., Vivian Thompson, M.P.H., Jonathan Janes, M.B., B.Ch., William L. Macias, M.D., Ph.D., Burkhard Vangerow, M.D., and Mark D. Williams, M.D. For the PROWESS-SHOCK Study Group: Drotrecogin Alfa in Adults with Septic Shock Recombinant human activated protein C, or drotrecogin alfa , was approved for the treating severe sepsis in 2001 on the basis of the Prospective Recombinant Human Activated Protein C World-wide Evaluation in Severe Sepsis study,1 a phase 3 international, randomized, controlled trial that was stopped early for efficacy after the enrollment of 1690 patients with severe sepsis. Absolute mortality in the intention-to-treat populace was reduced by 6.1 %age factors, a relative risk reduction of 19.4 percent.